Deficits in GABAA receptor function and working memory in non-smokers with schizophrenia

Schizophrenia Research

Volumn 171, Issue 1-3, 2016, Pages 125-130

  Bridgman, Alanna C ^a   Barr, Mera S ^a,b   Goodman, Michelle S ^a   Chen, Robert ^c   Rajji, Tarek K ^a,b   Daskalakis, Zafiris J ^a,b   George, Tony P ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cortical inhibition; Gamma aminobutyric acid; N back task; Transcranial magnetic stimulation

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GABAERGIC TRANSMISSION; HUMAN; MALE; MEMORY DISORDER; MENTAL TASK; MOLECULAR PATHOLOGY; NERVE EXCITABILITY; NEUROPATHOLOGY; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION; VERBAL N BACK TASK; WORKING MEMORY; ADOLESCENT; ANALYSIS OF VARIANCE; COMPLICATION; DEFICIENCY; ELECTROMYOGRAPHY; MEMORY DISORDERS; MIDDLE AGED; MOTOR EVOKED POTENTIAL; NERVE CELL INHIBITION; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; REACTION TIME; SHORT TERM MEMORY; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MIDDLE AGED; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; RECEPTORS, GABA; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 84958107903     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2016.01.008     Document Type: Article

References (47)

1. Albuquerque E.X., Alkondon M., Pereira E.F., Castro N.G., Schrattenholz A., Barbosa C.T., Bonfante-Cabarcas R., Aracava Y., Eisenberg H.M., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 1997, 280(3):1117-1136.
2. Baddeley A., Logie R., Bressi S., Della Sala S., Spinnler H. Dementia and working memory. Q. J. Exp. Psychol. A 1986, 38(4):603-618.
3. Barr M.S., Farzan F., Tran L.C., Chen R., Fitzgerald P.B., Daskalakis Z.J. Evidence for excessive frontal evoked gamma oscillatory activity in schizophrenia during working memory. Schizophr. Res. 2010, 121(1-3):146-152.
4. Barr M.S., Farzan F., Arenovich T., Chen R., Fitzgerald P.B., Daskalakis Z.J. The effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophrenia. PLoS One 2011, 6(7).
5. Barr M.S., Farzan F., Rajji T.K., Voineskos A.N., Blumberger D.M., Arenovich T., Fitzgerald P.B., Daskalakis Z.J. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol. Psychiatry 2013, 73(6):510-517.
6. Boroojerdi B., Foltys H., Krings T., Spetzger U., Thron A., Topper R. Localization of the motor hand area using transcranial magnetic stimulation and functional magnetic resonance imaging. Clin. Neurophysiol. 1999, 110(4):699-704.
7. Cantello R., Gianelli M., Civardi C., Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992, 42(10):1951-1959.
8. Chen C.M., Stanford A.D., Mao X., Abi-Dargham A., Shungu D.C., Lisanby S.H., Schroeder C.E., Kegeles L.S. GABA level, gamma oscillation, and working memory performance in schizophrenia. NeuroImage 2014, 4:531-539.
9. Chu J., Gunraj C., Chen R. Possible differences between the time courses of presynaptic and postsynaptic GABAB mediated inhibition in the human motor cortex. Exp. Brain Res. 2008, 184(4):571-577.
10. Daskalakis Z.J., Christensen B.K., Chen R., Fitzgerald P.B., Zipursky R.B., Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch. Gen. Psychiatry 2002, 59(4):347-354.
11. Daskalakis Z.J., Farzan F., Barr M.S., Maller J.J., Chen R., Fitzgerald P.B. Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study. Neuropsychopharmacology 2008, 33(12):2860-2869.
12. Depp C.A., Bowie C.R., Mausbach B.T., Wolyniec P., Thornquist M.H., Luke J.R., McGrath J.A., Pulver A.E., Patterson T.L., Harvey P.D. Current smoking is associated with worse cognitive and adaptive functioning in serious mental illness. Acta Psychiatr. Scand. 2015.
13. Di Lazzaro V., Oliviero A., Pilato F., Mazzone P., Insola A., Ranieri F., Tonali P.A. Corticospinal volleys evoked by transcranial stimulation of the brain in conscious humans. Neurol. Res. 2003, 25(2):143-150.
14. Farzan F., Barr M.S., Levinson A.J., Chen R., Wong W., Fitzgerald P.B., Daskalakis Z.J. Reliability of long-interval cortical inhibition in healthy human subjects: a TMS-EEG study. J. Neurophysiol. 2010, 104(3):1339-1346.
15. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. SCID-I/P). Biometrics Research 2002, New York State Psychiatric Institute, New York, (Revision: January 2010).
16. Fitzgerald P.B., Brown T.L., Daskalakis Z.J. The application of transcranial magnetic stimulation in psychiatry and neurosciences research. Acta Psychiatr. Scand. 2002, 105(5):324-340.
17. Forbes N.F., Carrick L.A., McIntosh A.M., Lawrie S.M. Working memory in schizophrenia: a meta-analysis. Psychol. Med. 2009, 39(6):889-905.
18. Frankle W.G., Cho R.Y., Prasad K.M., Mason N.S., Paris J., Himes M.L., Walker C., Lewis D.A., Narendran R. In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients. Am. J. Psychiatry 2015, (appiajp201514081031).
19. Goldman-Rakic P.S. Regional and cellular fractionation of working memory. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(24):13473-13480.
20. Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J. Clin. Psychiatry 2006, 67(Suppl. 9):3-8. (discussion 36-42).
21. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
22. Kimiskidis V.K., Papagiannopoulos S., Kazis D.A., Sotirakoglou K., Vasiliadis G., Zara F., Kazis A., Mills K.R. Lorazepam-induced effects on silent period and corticomotor excitability. Exp. Brain Res. 2006, 173(4):603-611.
23. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., Asselman P., Marsden C.D. Corticocortical inhibition in human motor cortex. J. Physiol. 1993, 471:501-519.
24. Kukowski B., Haug B. Quantitative evaluation of the silent period, evoked by transcranial magnetic stimulation during sustained muscle contraction, in normal man and in patients with stroke. Electromyogr. Clin. Neurophysiol. 1992, 32(7-8):373-378.
25. Lang N., Hasan A., Sueske E., Paulus W., Nitsche M.A. Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study. Neuropsychopharmacology 2008, 33(10):2517-2523.
26. Lee J., Park S. Working memory impairments in schizophrenia: a meta-analysis. J. Abnorm. Psychol. 2005, 114(4):599-611.
27. Levy W.J. Transcranial stimulation of the motor cortex to produce motor-evoked potentials. Med. Instrum. 1987, 21(5):248-254.
28. McGrath J., Saha S., Chant D., Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 2008, 30:67-76.
29. Nakamura Y., Tsuji K., Shuto M., Ogita K., Yoneda Y., Shimamoto K., Shibata T., Kataoka K. Protection by diphenyliodonium against glutamate neurotoxicity due to blocking of N-methyl-d-aspartate receptors. Neuroscience 1997, 76(2):459-466.
30. Nuechterlein K.H., Subotnik K.L., Green M.F., Ventura J., Asarnow R.F., Gitlin M.J., Yee C.M., Gretchen-Doorly D., Mintz J. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr. Bull. 2011, 37(Suppl. 2):S33-S40.
31. Nutt D. GABAA receptors: subtypes, regional distribution, and function. J. Clin. Sleep Med. 2006, 2(2):S7-11.
32. Radhu N., de Jesus D.R., Ravindran L.N., Zanjani A., Fitzgerald P.B., Daskalakis Z.J. A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders. Clin. Neurophysiol. 2013, 124(7):1309-1320.
33. Salavati B., Rajji T.K., Price R., Sun Y., Graff-Guerrero A., Daskalakis Z.J. Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation. Schizophr. Bull. 2015, 41(1):44-56.
34. Sanger T.D., Garg R.R., Chen R. Interactions between two different inhibitory systems in the human motor cortex. J. Physiol. 2001, 530(Pt 2):307-317.
35. Schicktanz N., Schwegler K., Fastenrath M., Spalek K., Milnik A., Papassotiropoulos A., Nyffeler T., de Quervain D.J. Motor threshold predicts working memory performance in healthy humans. Ann. Clin. Transl. Neurol. 2014, 1(1):69-73.
36. Takahashi S., Ukai S., Kose A., Hashimoto T., Iwatani J., Okumura M., Tsuji T., Shinosaki K. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia. Schizophr. Res. 2013, 146(1-3):238-243.
37. Thibaut F., Boutros N.N., Jarema M., Oranje B., Hasan A., Daskalakis Z.J., Wichniak A., Schmitt A., Riederer P., Falkai P., Wfsbp Task Force on Biological, M. Consensus paper of the WFSBP task force on biological markers: criteria for biomarkers and endophenotypes of schizophrenia part I: neurophysiology. World J. Biol. Psychiatry 2015, 16(5):280-290.
38. Tse M.T., Piantadosi P.T., Floresco S.B. Prefrontal cortical gamma-aminobutyric acid transmission and cognitive function: drawing links to schizophrenia from preclinical research. Biological Psychiatry 2014.
39. Valls-Sole J., Pascual-Leone A., Wassermann E.M., Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr. Clin. Neurophysiol. 1992, 85(6):355-364.
40. Volk D.W., Lewis D.A. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol. Behav. 2002, 77(4-5):501-505.
41. Walker M.C., Semyanov A. Regulation of excitability by extrasynaptic GABA(A) receptors. Results Probl. Cell Differ. 2008, 44:29-48.
42. Wechsler D. Wechsler Test of Adult Reading (WTAR) 2001, The Psychological Corporation, San Antonio, TX.
43. Wobrock T., Schneider M., Kadovic D., Schneider-Axmann T., Ecker U.K., Retz W., Rosler M., Falkai P. Reduced cortical inhibition in first-episode schizophrenia. Schizophr. Res. 2008, 105(1-3):252-261.
44. Wobrock T., Schneider-Axmann T., Retz W., Rosler M., Kadovic D., Falkai P., Schneider M. Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation. Pharmacopsychiatry 2009, 42(5):194-201.
45. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003, 64(6):663-667.
46. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann. Neurol. 1996, 40(3):367-378.
47. Ziemann U., Tergau F., Wischer S., Hildebrandt J., Paulus W. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalogr. Clin. Neurophysiol. 1998, 109(4):321-330.